NOV 29, 2016 11:22 AM PST

Should Healthy Women Take Breast Cancer Drugs?

WRITTEN BY: Xuan Pham
New recommendations from the National Institute for Health and Care Excellence (NICE) in the UK suggest that women preemptively take breast cancer drugs to prevent breast cancer. But is it wise (or even safe) for otherwise healthy women?
 

"Our draft guideline update recommends the use of anastrozole as a first-line treatment for post-menopausal women at high or medium risk of breast cancer who don't have osteoporosis,” said Mark Baker from NICE.
 
"The evidence examined by the committee suggests anastrozole will not only reduce the number of breast cancer cases in these women compared to tamoxifen, but it is also a more cost-effective option."
 
Anastrozole is a medication that lowers estrogen hormone levels in women, and thereby helps to shrink tumors. Similarly, tamoxifen blocks estrogen from attaching to cancer cells, thereby also reducing tumor growth. Both drugs are commonly prescribed to fight breast tumors.
 

Of note, tamoxifen is approved by the FDA for the prevention of invasive breast cancer in high-risk women. These include women who have a family history of the disease, or who themselves have high-risk mutations in the BRCA 1 and/or BRCA 2 genes.
 
The new guidelines aim to extend preventative measures with the use of anastrozole. However, since this drug is not yet approved solely for prevention of breast cancer, doctors would have to prescribe this drug off-label.
 
"This updated guideline is a great first step but we now need to ensure that these risk-reducing options actually make their way to patients that could benefit. Ultimately, if the full potential of anastrozole is to be realized for post-menopausal women, there needs to be far greater awareness and support for [doctors] in prescribing off-label treatments,” said Baroness Morgan, Chief Executive of the charity Breast Cancer Now in the UK.
 
However, patients and physicians must also weigh the risks of side effects with the preventative medicines. Being chemotherapy drugs, both anastrozole and tamoxifen are associated with severe side effects, such as nausea, vomiting, pain and weakness. In addition, because the drugs affect the estrogen, women may experience hormonal changes, such as hot flashes, weight change, and hair loss. 
 

Additional sources: BBC News
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 03, 2019
Cancer
DEC 03, 2019
Using deep learning to find the patterns of cancer
Research published recently in the journal Life Science Alliance uses deep learning to analyze genomic data from colorectal tumors to ameliorate diagnosis ...
DEC 08, 2019
Cancer
DEC 08, 2019
Why do colder, wetter climates have a higher prevalence of cancer?
You might want to sit down, because this news may come as a surprise: researchers have found an association between cold, wet climates and increased cancer...
DEC 14, 2019
Cancer
DEC 14, 2019
Common antibiotic could improve radiation therapy
Have you ever taken the antibiotic vancomycin? As a commonly prescribed antibiotic for colitis and infections caused by Clostridium difficile, vancomycin i...
DEC 16, 2019
Cell & Molecular Biology
DEC 16, 2019
When Migrating, Cancer Cells Choose the Path of Least Resistance
Cancer becomes most deadly when it has metastasized - when cancerous cells move away from the site where cancer started growing....
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
FEB 04, 2020
Health & Medicine
FEB 04, 2020
World Health Organization Outlines Strategy to Eradicate Cervical Cancer
Today—World Cancer Day—the World Health Organization (WHO) announced a draft of a global strategy to eliminate cervical cancer as a public heal...
Loading Comments...